SK279927B6 - Orálne pevné farmaceutické prípravky obsahujúce ge - Google Patents

Orálne pevné farmaceutické prípravky obsahujúce ge Download PDF

Info

Publication number
SK279927B6
SK279927B6 SK605-95A SK60595A SK279927B6 SK 279927 B6 SK279927 B6 SK 279927B6 SK 60595 A SK60595 A SK 60595A SK 279927 B6 SK279927 B6 SK 279927B6
Authority
SK
Slovakia
Prior art keywords
gemfibrozil
dissolution
surfactant
tablets
active ingredient
Prior art date
Application number
SK605-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK60595A3 (en
Inventor
P�L Fekete
Erzs�Bet Fellner
Andrea S�Ndorfalvy
D�Nes Bezzegh
Gyrgy Ujfalussy
Magdolna G�Ra
Imre Klebovich
S�Ndor Drabant
Attila M�Ndi
B�Borka Maroshelyi
M�Rta Sz�Nt�
Zsuzsa Szl�Vy
Original Assignee
Egis Gy�Gyszergy�R Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gy�Gyszergy�R Rt. filed Critical Egis Gy�Gyszergy�R Rt.
Publication of SK60595A3 publication Critical patent/SK60595A3/sk
Publication of SK279927B6 publication Critical patent/SK279927B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SK605-95A 1994-05-13 1995-05-10 Orálne pevné farmaceutické prípravky obsahujúce ge SK279927B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9401506A HU212428B (en) 1994-05-13 1994-05-13 Process to prepare pharmaceutical compositions containing gemfibrozyl
US08/441,687 US5726201A (en) 1994-05-13 1995-05-15 Gemfibrozil containing pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SK60595A3 SK60595A3 (en) 1996-05-08
SK279927B6 true SK279927B6 (sk) 1999-05-07

Family

ID=26318196

Family Applications (1)

Application Number Title Priority Date Filing Date
SK605-95A SK279927B6 (sk) 1994-05-13 1995-05-10 Orálne pevné farmaceutické prípravky obsahujúce ge

Country Status (17)

Country Link
US (1) US5726201A (it)
EP (1) EP0684042B1 (it)
JP (1) JP2934941B2 (it)
AT (1) ATE160938T1 (it)
AU (1) AU1768095A (it)
CA (1) CA2149282A1 (it)
CZ (1) CZ287149B6 (it)
DE (1) DE69501183T2 (it)
ES (1) ES2113136T3 (it)
FR (1) FR2719771B1 (it)
GB (1) GB2291349B (it)
GR (1) GR3025749T3 (it)
HR (1) HRP950268B1 (it)
HU (1) HU212428B (it)
IT (1) IT1274483B (it)
PL (1) PL179806B1 (it)
SK (1) SK279927B6 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
WO2002043694A2 (en) 2000-11-28 2002-06-06 Fmc Corporation Edible pga(propylene glycol alginate) coating composition
US6841865B2 (en) * 2002-11-22 2005-01-11 International Rectifier Corporation Semiconductor device having clips for connecting to external elements
NZ546337A (en) * 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4126637A (en) * 1977-06-17 1978-11-21 Warner-Lambert Company Process for the production of 2,2-dimethyl-5-(2,5-xylyloxy)valeric acid
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4971804A (en) * 1989-02-02 1990-11-20 Warner-Lambert Company Water dispersible gemfibrozil compositions
US4925676A (en) * 1989-02-02 1990-05-15 Warner-Lambert Company Extended release gemfibrozil composition
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
EP0462067A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil formulations
EP0475894A1 (en) * 1990-08-27 1992-03-18 Warner-Lambert Company Gemfibrozil formulations
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system

Also Published As

Publication number Publication date
EP0684042A2 (en) 1995-11-29
CA2149282A1 (en) 1995-11-14
EP0684042B1 (en) 1997-12-10
DE69501183D1 (de) 1998-01-22
ITMI950961A1 (it) 1996-11-12
PL179806B1 (pl) 2000-10-31
GB2291349B (en) 1998-03-18
IT1274483B (it) 1997-07-17
GR3025749T3 (en) 1998-03-31
ITMI950961A0 (it) 1995-05-12
AU1768095A (en) 1995-11-23
SK60595A3 (en) 1996-05-08
JP2934941B2 (ja) 1999-08-16
ATE160938T1 (de) 1997-12-15
FR2719771B1 (fr) 1997-01-03
GB2291349A (en) 1996-01-24
EP0684042A3 (en) 1996-05-15
FR2719771A1 (fr) 1995-11-17
HU212428B (en) 1996-06-28
HRP950268A2 (en) 1997-08-31
CZ287149B6 (en) 2000-09-13
CZ122895A3 (en) 1995-12-13
HRP950268B1 (en) 1999-02-28
PL308580A1 (en) 1995-11-27
US5726201A (en) 1998-03-10
HUT70961A (en) 1995-11-28
ES2113136T3 (es) 1998-04-16
HU9401506D0 (en) 1994-08-29
GB9509542D0 (en) 1995-07-05
DE69501183T2 (de) 1998-05-07
JPH0899875A (ja) 1996-04-16

Similar Documents

Publication Publication Date Title
EP1562573B1 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
JP3190299B2 (ja) 迅速に分解する改良多粒子錠剤
EP0218148B1 (en) Slow-release pharmaceutical composition
US20090124702A1 (en) Pharmaceutical Compositions of Metformin
JP4787446B2 (ja) グリブリド組成物
SK155595A3 (en) Tablet and manufacturing process thereof
JPH0122245B2 (it)
NZ205894A (en) Pharmaceutical compositions containing mopidamol(2,6-bis(diethanolamino)-4-piperidino-pyrimido(5,4-d)pyrimidine)
SK7562000A3 (en) Spheroids, preparation method and pharmaceutical compositions
IE880855L (en) Slow-release pharmaceutical agent
IE64659B1 (en) Pimobendan compositions
US20040142033A1 (en) Pharmaceutical composition, containing oxcarbazepine with sustained release of an active-ingredient
JP2014196334A (ja) クエチアピンを含む徐放性医薬組成物
US5322698A (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
US20040115264A1 (en) Fenofibrate tablets
SK279927B6 (sk) Orálne pevné farmaceutické prípravky obsahujúce ge
AU2002333896B2 (en) Solid pharmaceutical formulation for a piperazine urea derivative
EA002428B1 (ru) Стабильные композиции, содержащие левозимендан и альгиновую кислоту
RU2152209C1 (ru) Гемфиброзил-содержащие фармацевтические композиции
WO2003013480A1 (en) Improved enteric formulation of fluoxetin
SK11072000A3 (sk) Tiagabínové prostriedky s predĺženým uvoľňovaním so zníženými vedľajšími účinkami
US20030087913A1 (en) Solid pharmaceutical agent formulation for a piperazine urea derivative
PL199813B1 (pl) Stały doustny preparat farmaceutyczny acebutololu o przedłużonym uwalnianiu i sposób jego wytwarzania